Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
LivaNova
LIVN
$4.34B
| $7.44M | 0.02% |
189,316
+52,971
| +39% | +$2.38M |
|
602
Flowserve
FLS
$10.1B
| $7.42M | 0.02% |
151,969
+131,483
| +642% | +$7.47M |
|
603
PUT
Hims & Hers Health
HIMS
$7.88B
| $7.41M | 0.02% |
250,700
+88,400
| +54% | +$3.28M |
|
604
Resideo Technologies
REZI
$3.08B
| $7.41M | 0.02% |
418,516
+293,287
| +234% | +$6.02M |
|
605
The Greenbrier Companies
GBX
$1.42B
| $7.4M | 0.02% |
144,505
+37,555
| +35% | +$2.24M |
|
606
Terex
TEX
$7.6B
| $7.4M | 0.02% |
195,877
+133,815
| +216% | +$5.84M |
|
607
Celanese
CE
$5.14B
| $7.4M | 0.02% |
130,351
+7,194
| +6% | +$449K |
|
608
CNO Financial Group
CNO
$4.95B
| $7.39M | 0.02% |
177,513
+166,997
| +1,588% | +$6.67M |
|
609
AB InBev
BUD
$155B
| $7.37M | 0.02% |
119,752
-133,973
| -53% | -$7.33M |
|
610
Packaging Corp of America
PKG
$22.5B
| $7.36M | 0.02% |
37,144
+33,704
| +980% | +$7.19M |
|
611
TransDigm Group
TDG
$66.4B
| $7.34M | 0.02% |
+5,306
| New | +$7.07M |
|
612
PUT
Crown Castle
CCI
$32.1B
| $7.34M | 0.02% |
70,400
+43,100
| +158% | +$4.02M |
|
613
A10 Networks
ATEN
$1.9B
| $7.33M | 0.02% |
448,840
+149,551
| +50% | +$2.87M |
|
614
Itron
ITRI
$4.38B
| $7.32M | 0.02% |
+69,918
| New | +$7.32M |
|
615
iShares MSCI USA Quality Factor ETF
QUAL
$47.7B
| $7.32M | 0.02% |
+42,826
| New | +$7.67M |
|
616
W.W. Grainger
GWW
$61.8B
| $7.31M | 0.02% |
7,398
+363
| +5% | +$375K |
|
617
VanEck Gold Miners ETF
GDX
$32B
| $7.3M | 0.02% |
158,737
-220,454
| -58% | -$8.91M |
|
618
Factset
FDS
$10.7B
| $7.28M | 0.02% |
16,007
+14,752
| +1,175% | +$6.72M |
|
619
Flywire
FLYW
$2.38B
| $7.26M | 0.02% |
764,397
+349,805
| +84% | +$5.51M |
|
620
PUT
Rocket Lab Corp
RKLB
$46.4B
| $7.22M | 0.02% |
404,000
+113,700
| +39% | +$2.72M |
|
621
PUT
Blackrock
BLK
$179B
| $7.19M | 0.02% |
7,600
+2,300
| +43% | +$2.25M |
|
622
Assured Guaranty
AGO
$3.27B
| $7.19M | 0.02% |
+81,588
| New | +$7.32M |
|
623
CALL
Scorpio Tankers
STNG
$3.93B
| $7.17M | 0.02% |
190,800
+71,200
| +60% | +$3.19M |
|
624
iShares MSCI Brazil ETF
EWZ
$8.04B
| $7.16M | 0.02% |
277,134
+203,414
| +276% | +$5.07M |
|
625
Fidelity National Financial
FNF
$12.7B
| $7.14M | 0.02% |
109,685
-274
| -0.2% | -$16.5K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.